Malignant Bowel Obstruction
📧 Sign up to get email alerts when something new happens for Malignant Bowel Obstruction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites [NA]
A clinical trial update for a study comparing Kinesio-Taping versus usual care in patients with malignant bowel obstruction and ascites, cur…
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Palliative Management of Inoperable Malignant Bowel Obstruction [Phase 2]
A Phase 2 clinical trial update on palliative management for inoperable malignant bowel obstruction has been terminated; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Quality of Life in Patients With Inoperable Malignant Bowel Obstruction [Phase 2]
Phase 2 clinical trial updating quality of life in patients with inoperable malignant bowel obstruction (intestinal obstruction) was termina…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction [Phase 1, Phase 2]
This Phase 1/2 clinical trial tests best supportive care with either cisplatin or paclitaxel for patients with ovarian cancer, primary perit…
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer [NA]
A Mayo Clinic trial evaluating nicotine to treat hunger pain in patients with malignant bowel obstruction due to cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients [Phase 2]
Phase 2 trial evaluating lanreotide 120 mg as palliative treatment for symptoms of malignant bowel obstruction in inoperable patients; the s…